Male Contraception: Promising New Approaches

[1]  E. Nieschlag,et al.  Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies. , 1999, European journal of endocrinology.

[2]  E. Nieschlag,et al.  The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. , 1997, Endocrine reviews.

[3]  W. Bremner,et al.  An oral regimen of cyproterone acetate and testosterone undecanoate for spermatogenic suppression in men. , 1997, Fertility and sterility.

[4]  T. Maatman,et al.  Patient noncompliance after vasectomy. , 1997, Fertility and sterility.

[5]  J. Crow.  The high spontaneous mutation rate: is it a health risk? , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[6]  E. Nieschlag,et al.  Paracrine regulation of cellular interactions in the testis: factors in search of a function. , 1997, European journal of endocrinology.

[7]  M. Sairam,et al.  Immunization of male bonnet monkeys (M. radiata) with a recombinant FSH receptor preparation affects testicular function and fertility. , 1997, Endocrinology.

[8]  R. Swerdloff,et al.  Oligozoospermia induced by exogenous testosterone is associated with normal functioning residual spermatozoa. , 1997, Fertility and sterility.

[9]  G. P. Talwar,et al.  Fertility regulating and immunotherapeutic vaccines reaching human trials stage. , 1997, Human reproduction update.

[10]  E. Nieschlag,et al.  High loading and low maintenance doses of a gonadotropin-releasing hormone antagonist effectively suppress serum luteinizing hormone, follicle-stimulating hormone, and testosterone in normal men. , 1997, The Journal of clinical endocrinology and metabolism.

[11]  J. Suvisaari,et al.  Pharmacokinetics and pharmacodynamics of 7alpha-methyl-19-nortestosterone after intramuscular administration in healthy men. , 1997, Human reproduction.

[12]  R. Douglas.  Perspectives on Hepatitis B Vaccination-Reply , 1997 .

[13]  L. Edouard.  On the determination of contraceptive prevalence using health care utilization data. , 1997, Journal of clinical epidemiology.

[14]  M. Skriver,et al.  Conventional or Li vasectomy: a questionnaire study. , 1997, British journal of urology.

[15]  G. Shetty,et al.  Effect of estrogen deprivation on the reproductive physiology of male and female primates , 1997, The Journal of Steroid Biochemistry and Molecular Biology.

[16]  J Warszawski,et al.  Condom breakage and slippage during heterosexual intercourse: a French national survey. French National Survey on Sexual Behavior Group (ACSF). , 1997, American journal of public health.

[17]  S. Gupta,et al.  The HSD‐hCG Vaccine Prevents Pregnancy in Women: Feasibility Study of a Reversible Safe Contraceptive Vaccine , 1997, American journal of reproductive immunology.

[18]  J. Slootstra,et al.  In vitro inhibition of the biological activity of follicle-stimulating hormone by anti-peptide antisera representing the human follicle-stimulating hormone beta subunit sequence 33-53. , 1997, Biology of reproduction.

[19]  J. Herr,et al.  Sperm Antigens and Their Use in the Development of an Immunocontraceptive , 1997, American journal of reproductive immunology.

[20]  C. Kent,et al.  Contraceptive practices before and after an intervention promoting condom use to prevent HIV infection and other sexually transmitted diseases among women--selected U.S. sites, 1993-1995. , 1997, MMWR. Morbidity and mortality weekly report.

[21]  J. Lansac.  Epididymis: Role and importance in male infertility treatment , 1996 .

[22]  A. Aribarg,et al.  Suppression of spermatogenesis by testosterone enanthate in Thai men. , 1996, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[23]  W. Bremner,et al.  A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive. , 1996, The Journal of clinical endocrinology and metabolism.

[24]  F. Jockenhövel,et al.  Pharmacokinetics and pharmacodynamics of subcutaneous testosterone implants in hypogonadal men , 1996, Clinical endocrinology.

[25]  S. Coonrod,et al.  Inhibition of bovine fertilization in vitro by antibodies to SP-10. , 1996, Journal of reproduction and fertility.

[26]  P. McDonough,et al.  Correction to "World Health Organization Task Force on Methods for the Regulation of Male Fertility. Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. Fertil Steril 1996;65:821-9." , 1996 .

[27]  W. Puijk,et al.  Detection of epitopes on follicle-stimulating hormone and FSH-antiserum-induced suppression of bioactivity of follicle-stimulating hormone and luteinizing hormone. , 1996, Journal of reproductive immunology.

[28]  I. Milsom,et al.  A comparison of contraceptive habits and pregnancy outcome at 19 years of age in two cohorts of Swedish women born 1962 and 1972. , 1996, Contraception.

[29]  L. Shen,et al.  Morphological observations of vas deferens occlusion by the percutaneous injection of medical polyurethane. , 1996, Contraception.

[30]  E. Nieschlag,et al.  An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man. , 1996, The Journal of clinical endocrinology and metabolism.

[31]  M. Potts.  The myth of a male pill , 1996, Nature Medicine.

[32]  R. Anderson,et al.  Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone. , 1996, The Journal of clinical endocrinology and metabolism.

[33]  A. Matsumoto,et al.  Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach. , 1996, The Journal of clinical endocrinology and metabolism.

[34]  P. Primakoff,et al.  Initial evaluation of fertilin as an immunocontraceptive antigen and molecular cloning of the cynomolgus monkey fertilin β subunit , 1996, Molecular reproduction and development.

[35]  L. Russell,et al.  The leydig cell , 1996 .

[36]  E. Nieschlag,et al.  Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders. , 1995, The Journal of clinical endocrinology and metabolism.

[37]  T. Cooper,et al.  Effects of the male antifertility agent ornidazole on sperm function in vitro and in the female genital tract. , 1995, Journal of reproduction and fertility.

[38]  E. Goldberg,et al.  Reversible contraception in female baboons immunized with a synthetic epitope of sperm-specific lactate dehydrogenase. , 1995, Biology of reproduction.

[39]  Q S Zhen,et al.  Recent progress in research on Tripterygium: a male antifertility plant. , 1995, Contraception.

[40]  David Handelsman,et al.  Factors in nonuniform induction of azoospermia by testosterone enanthate in normal men. World Health Organization Task Force on Methods for the Regulation of Male Fertility. , 1995, Fertility and sterility.

[41]  Reynolds Rd.  Vas deferens occlusion during no-scalpel vasectomy. , 1994 .

[42]  A. Visser,et al.  Contraceptive use and attitudes in reunified Germany. , 1994, European journal of obstetrics, gynecology, and reproductive biology.

[43]  E. Nieschlag,et al.  High efficacy of gonadotropin or pulsatile gonadotropin-releasing hormone treatment in hypogonadotropic hypogonadal men. , 1994, European journal of endocrinology.

[44]  I. de Vincenzi,et al.  A Longitudinal Study of Human Immunodeficiency Virus Transmission by Heterosexual Partners , 1994 .

[45]  C. Djerassi,et al.  A new look at male contraception , 1994, Nature.

[46]  U. Engelmann,et al.  Risk Factors for Antisperm Antibodies in Infertile Men , 1994, American journal of reproductive immunology.

[47]  R. Mclachlan,et al.  Testosterone effects on spermatogenesis in the gonadotropin-releasing hormone-immunized rat. , 1994, Biology of reproduction.

[48]  Jacques Young,et al.  Failure of combined follicle-stimulating hormone-testosterone administration to initiate and/or maintain spermatogenesis in men with hypogonadotropic hypogonadism. , 1993, The Journal of clinical endocrinology and metabolism.

[49]  S. Li,et al.  Vasal sterilization in China. , 1993, Contraception.

[50]  David Handelsman,et al.  Suppression of human spermatogenesis by testosterone implants. , 1992, The Journal of clinical endocrinology and metabolism.

[51]  R. Dighe,et al.  Long-term contraceptive efficacy of vaccine of ovine follicle-stimulating hormone in male bonnet monkeys (Macaca radiata). , 1992, Journal of reproduction and fertility.

[52]  B. Hurst,et al.  Immunoneutralization of gonadotropin-releasing hormone and subsequent treatment with testosterone Silastic implants in rats: an approach toward developing a male contraceptive. , 1992, Fertility and sterility.

[53]  S. Garde,et al.  Passive immunization against prostatic 'inhibin' peptide as a male contraceptive. , 1992, International journal of andrology.

[54]  T. Cooper.  The Epididymis as a Site of Contraceptive Attack , 1992 .

[55]  E. Nieschlag,et al.  Hormonal Male Contraception: A Real Chance? , 1992 .

[56]  E. Nieschlag,et al.  Spermatogenesis — Fertilization — Contraception , 1992, Schering Foundation Workshop.

[57]  E. Nieschlag,et al.  Human follicle-stimulating hormone exerts a stimulatory effect on spermatogenesis, testicular size, and serum inhibin levels in the gonadotropin-releasing hormone antagonist-treated nonhuman primate (Macaca fascicularis). , 1991, Endocrinology.

[58]  David Handelsman,et al.  Contraceptive efficacy of testosterone‐induced azoospermia in normal men , 1991 .

[59]  S C Zhao,et al.  Vas deferens occlusion by percutaneous injection of polyurethane elastomer plugs: clinical experience and reversibility. , 1990, Contraception.

[60]  J. Trussell,et al.  Contraceptive failure in the United States: an update. , 1990, Studies in family planning.

[61]  E. Nieschlag,et al.  Sustained inhibition of sperm production and inhibin secretion induced by a gonadotrophin-releasing hormone antagonist and delayed testosterone substitution in non-human primates (Macaca fascicularis). , 1989, The Journal of endocrinology.

[62]  E. Nieschlag,et al.  Combination of 19-nortestosterone-hexyloxyphenylpropionate (Anadur) and depot-medroxyprogesterone-acetate (Clinovir) for male contraception. , 1989 .

[63]  C. Monder,et al.  In Vitro Metabolism of 7α-Methyl-19-Nortestosterone by Rat Liver, Prostate, and Epididymis , 1988 .

[64]  P. Primakoff,et al.  Fully effective contraception in male and female guinea pigs immunized with the sperm protein PH-20 , 1988, Nature.

[65]  E. Nieschlag,et al.  Testosterone prevents complete suppression of spermatogenesis in the gonadotropin-releasing hormone antagonist-treated nonhuman primate (Macaca fascicularis). , 1988, The Journal of clinical endocrinology and metabolism.

[66]  H. Rodbard,et al.  Gonadotropin therapy in men with isolated hypogonadotropic hypogonadism: the response to human chorionic gonadotropin is predicted by initial testicular size. , 1988, The Journal of clinical endocrinology and metabolism.

[67]  A. Matsumoto,et al.  Chronic human chorionic gonadotropin administration in normal men: evidence that follicle-stimulating hormone is necessary for the maintenance of quantitatively normal spermatogenesis in man. , 1986, The Journal of clinical endocrinology and metabolism.

[68]  E. Nieschlag,et al.  Clinical trial of 19-nortestosterone-hexoxyphenylpropionate (Anadur) for male fertility regulation. , 1985, Fertility and Sterility.

[69]  E. Nieschlag,et al.  Testosterone supplementation attenuates the antifertility effects of an LHRH agonist in male rhesus monkeys. , 1983, International journal of andrology.

[70]  A. Matsumoto,et al.  Reinitiation of sperm production in gonadotropin-suppressed normal men by administration of follicle-stimulating hormone. , 1983, The Journal of clinical investigation.

[71]  E. Nieschlag,et al.  Active immunization with follicle-stimulating hormone for fertility control: a 4 1/2-year study in male rhesus monkeys. , 1983, Fertility and sterility.

[72]  K. Usadel,et al.  The role of follicle stimulating hormone in testicular function of the mature rhesus monkey. , 1980, Acta endocrinologica.

[73]  J. Hammerstein,et al.  Medium dose cyproterone acetate (CPA): effects on hormone secretion and on spermatogenesis in men. , 1980, Contraception.

[74]  C. Wang,et al.  Use of low-dosage oral cyproterone acetate as a male contraceptive. , 1980, Contraception.

[75]  N. Skakkebaek,et al.  The effects of low doses of cyproterone acetate on some functions of the reproductive system in normal men. , 1979, Acta endocrinologica.

[76]  E. Nieschlag,et al.  Clinical trial with testosterone undecanoate for male fertility control. , 1978, Contraception.

[77]  R. Lequin.  Immunization with hormones in reproduction research , 1976 .